Human milk proresolving mediators stimulate resolution of acute inflammation

Mucosal Immunology

Volumn 9, Issue 3, 2016, Pages 757-766

  Arnardottir, H ^a   Orr, S K ^a   Dalli, J ^a   Serhan, C N ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD59 ANTIGEN; LEUKOTRIENE B4; LIPOXIN; PROSTANOID; 7,14-DIHYDROXYDOCOSA-4,8,10,12,16,19-HEXAENOIC ACID; ANTIINFLAMMATORY AGENT; DOCOSAHEXAENOIC ACID; RESOLVIN D2;

ANIMAL EXPERIMENT; ARTICLE; BACTERIUM ISOLATE; BREAST MILK; CELL MIGRATION; CELL PHAGOCYTOSIS; ESCHERICHIA COLI; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LEUKOCYTE; LIPIDOMICS; LIQUID CHROMATOGRAPHY; MACROPHAGE; MASS SPECTROMETRY; MASTITIS; METABOLOMICS; MOUSE; NEUTROPHIL; NEUTROPHIL COUNT; NONHUMAN; NORMAL HUMAN; PERITONITIS; PRIORITY JOURNAL; ACUTE DISEASE; ANIMAL; APOPTOSIS; CELL CULTURE; CHEMICALLY INDUCED; CHEMISTRY; DISEASE MODEL; IMMUNOLOGY; INBRED MOUSE STRAIN; MALE; METABOLISM; PHAGOCYTOSIS;

ACUTE DISEASE; ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; HUMANS; MACROPHAGES; MALE; METABOLOMICS; MICE; MICE, INBRED STRAINS; MILK, HUMAN; NEUTROPHILS; PERITONITIS; PHAGOCYTOSIS;

EID: 84964931408     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2015.99     Document Type: Article

References (41)

1. Serhan, C.N. Pro-resolving lipid mediators are leads for resolution physiology. Nature 510, 92-101 (2014).
2. Fullerton, J.N., O'Brien, A.J. & Gilroy, D.W. Lipid mediators in immune dysfunction after severe inflammation. Trends Immunol. 35, 12-21 (2014).
3. Colas, R.A., Shinohara,M., Dalli, J., Chiang, N. & Serhan, C.N. Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue. Am. J. Physiol. Cell. Physiol. 307, C39-C54 (2014).
4. Claria, J., Nguyen, B.T., Madenci, A., Ozaki, C.K. & Serhan, C.N. Diversity of lipid mediators in human adipose tissue depots. Am. J. Physiol. Cell. Physiol. 304, C1141-C1149 (2013).
5. Keelan, J.A. et al. Effects of maternal n-3 fatty acid supplementation on placental cytokines, pro-resolving lipid mediators and their precursors. Reproduction 149, 171-178 (2015).
6. Weiss, G.A., Troxler, H., Klinke, G., Rogler, D., Braegger, C. & Hersberger, M. High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation. Lipids Health Dis. 12, 89 (2013).
7. Serhan, C.N. et al. Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J. Immunol. 171, 6856-6865 (2003).
8. Arita,M. et al.ResolvinE1, anendogenous lipidmediatorderivedfromomega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acidinduced colitis. Proc. Natl. Acad. Sci. USA 102, 7671-7676 (2005).
9. Bento, A.F.,Claudino, R.F., Dutra, R.C.,Marcon, R. & Calixto, J.B. Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice. J. Immunol. 187, 1957-1969 (2011).
10. Calder, P.C. et al. Early nutrition and immunity-progress and perspectives. Br. J. Nutr. 96, 774-790 (2006).
11. Peng, Y. et al. Fatty acid composition of diet, cord blood and breast milk in Chinese mothers with different dietary habits. Prostaglandins Leukot. Essent. Fatty Acids 81, 325-330 (2009).
12. Walker, W.A. Initial intestinal colonization in the human infant and immune homeostasis. Ann. Nutr. Metab. 63 (Suppl 2), 8-15 (2013).
13. Schwab, J.M., Chiang, N., Arita, M. & Serhan, C.N. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447, 869-874 (2007).
14. Bannenberg, G.L. et al. Molecular circuits of resolution: formation and actions of resolvins and protectins. J. Immunol. 174, 4345-4355 (2005).
15. Reid, B., Smith, H. & Friedman, Z. Prostaglandins in human milk. Pediatrics 66, 870-872 (1980).
16. Levy, B.D., Clish, C.B., Schmidt, B., Gronert, K. & Serhan, C.N. Lipid mediator class switching during acute inflammation: signals in resolution. Nat. Immunol. 2, 612-619 (2001).
17. Flower, R.J. Prostaglandins, bioassay and inflammation. Br. J. Pharmacol. 147, S182-S192 (2006).
18. Haeggstrom, J.Z. & Funk, C.D. Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease. Chem. Rev. 111, 5866-5898 (2011).
19. Chiang, N. et al. Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature 484, 524-528 (2012).
20. Spite, M. et al. Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature 461, 1287-1291 (2009).
21. Chen, R.F. Removal of fatty acids from serum albumin by charcoal treatment. J. Biol. Chem. 242, 173-181 (1967).
22. Chiang, N., Dalli, J., Colas, R.A. & Serhan, C.N. Identification of resolvin D2 receptor mediating resolution of infections and organ protection. J. Exp. Med. 212, 1203-1217 (2015).
23. Gronert, K., Gewirtz, A., Madara, J.L. & Serhan, C.N. Identification of a human enterocyte lipoxin A4 receptor that is regulated by IL-13 and IFN-gamma and inhibits TNF-alpha-induced IL-8 release. J. Exp. Med. 187, 1285-1294 (1998).
24. Gewirtz, A.T. et al. Pathogen-induced chemokine secretion from model intestinal epithelium is inhibited by lipoxin A4 analogs. J. Clin. Invest. 101, 1860-1869 (1998).
25. Campbell, E.L. et al. Resolvin E1-induced intestinal alkaline phosphatase promotes resolution of inflammation through LPS detoxification. Proc. Natl. Acad. Sci. USA 107, 14298-14303 (2010).
26. Morita, M. et al. The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza. Cell 153, 112-125 (2013).
27. Aitken, S.L., Corl, C.M. & Sordillo, L.M. Immunopathology of mastitis: insights into disease recognition and resolution. J. Mammary Gland Biol. Neoplasia 16, 291-304 (2011).
28. Marcon, R., Bento, A.F., Dutra, R.C., Bicca, M.A., Leite, D.F. & Calixto, J.B. Maresin 1, a proresolving lipid mediator derived from omega-3 polyunsaturated fatty acids, exerts protective actions in murine models of colitis. J. Immunol. 191, 4288-4298 (2013).
29. Recchiuti, A. et al. Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages. FASEB J. 28, 3090-3102 (2014).
30. World Health Organization. Long-Term Effects of Breastfeeding: A Systematic Review. Available athttp://www.who.int/maternal-child-adolescent/documents/breastfeeding-long-term-effects/en/2013.
31. Fidler, N., Sauerwald, T., Pohl, A., Demmelmair, H. & Koletzko, B. Docosahexaenoic acid transfer into human milk after dietary supplementation: A randomized clinical trial. J. Lipid Res. 41, 1376-1383 (2000).
32. Heaton, A.E., Meldrum, S.J., Foster, J.K., Prescott, S.L. & Simmer, K. Does docosahexaenoic acid supplementation in term infants enhance neurocognitive functioning in infancy? Front. Hum. Neurosci. 7, 774 (2013).
33. Mas, E., Croft, K.D., Zahra, P., Barden, A. & Mori, T.A. Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation. Clin. Chem. 58, 1476-1484 (2012).
34. Shevalye, H. et al. Effect of enriching the diet with menhaden oil or daily treatment with resolvin D1 on neuropathy in a mouse model of type 2 diabetes. J. Neurophysiol. 114, 199-208 (2015).
35. Fiala, M. et al. Omega-3 supplementation increases amyloid-beta phagocytosis and resolvin D1 in patients with minor cognitive impairment. FASEB J. 29, 2681-2689 (2015).
36. Terrando, N. et al. Aspirin-triggered resolvin D1 prevents surgery-induced cognitive decline. FASEB J. 27, 3564-3571 (2013).
37. Harrison, J.L. et al. Resolvins AT-D1 and E1 differentially impact functional outcome, post-traumatic sleep, and microglial activation following diffuse brain injury in the mouse. Brain Behav. Immun. 47, 131-140 (2015).
38. Sampaio, A.L.F., Dufton, N. & Perretti, M. Models of acute inflammation- air pouch, peritonitis, and ischemia-reperfusion. In Fundamentals of Inflammation (Serhan, C.N. & Ward, P.A. & Gilroy, D.W., eds) 329-337 (Cambridge University Press, New York, NY, 2010).
39. Winkler, J. et al. Resolvin D4 potent antiinflammatory proresolving actions confirmed via total synthesis. FASEB J. 29, Suppl, 285.10 (2015).
40. Janes, K.A. & Yaffe, M.B. Data-driven modelling of signal-transduction networks. Nat. Rev. Mol. Cell Biol. 7, 820-828 (2006).
41. Arnardottir,H.H., Dalli, J., Colas, R.A., Shinohara, M. & Serhan, C.N. Aging delays resolution of acute inflammation in mice: reprogramming the host response with novel nano-proresolving medicines. J. Immunol. 193, 4235-4244 (2014).